Disposables Advisor

Jun 01, 2008
BioPharm International
By BioPharm International Editors
The current focus on cost-of-goods (COGS) models is underplaying the benefits of disposables technology in biopharmaceutical manufacturing. The best method for accounting for the benefits of reduced and delayed capital expenditures is through the use of NPV analysis.
Apr 01, 2008
BioPharm International
By BioPharm International Editors
Disposable technologies that mimic the conventional stainless-steel bioreactor will be most readily adopted
Feb 01, 2008
BioPharm International
By BioPharm International Editors
The use of disposables has changed significantly in the biopharmaceutical industry.
native1_300x100
lorem ipsum